J.P. Morgan analyst David Karnovsky maintained a Hold rating on Cinemark Holdings (CNK – Research Report) today and set a price target of ...

On Friday, Cinemark Holdings, Inc. (CNK) stock saw a modest uptick, ending the day at $29.68 which represents a slight increase of $1.05 or 3.67% from the prior close of $28.63. The stock opened at ...

引言以PD1抗体为代表的肿瘤免疫治疗近年来取得了较大进展，改变了肿瘤的治疗模式，但目前响应率不到30%，对肝癌、结直肠癌等效果尤其不佳，亟需发展新的肿瘤免疫治疗策略和靶点。NK细胞在肿瘤免疫中发挥重要作用，具有应答快、抑瘤谱广、通用性好、毒性小等特点 ...

周四,Roth/MKM将Cinemark Holdings (NYSE:CNK)的股票目标价从之前的30美元上调至33美元,同时维持对该股的买入评级。此次调整是基于该公司近期一系列积极发展,包括第三季度表现超出预期。 Cinemark最近的成功与其第三季度票房业绩有关,该业绩超出预期并比预期提前一个季度转为正值。这一早期成就为Roth/MKM预计的为期两年多的强劲内容周期奠定了基础。 该公司还指出 ...

Cinemark (CNK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Cinemark Holdings, Inc. (CNK)股价飙升至52周新高29.07美元，反映出这家电影院连锁企业的显著转变。这一峰值代表了重大复苏，也显示了投资者对公司在充满挑战的市场中展现出的韧性的信心。过去一年，Cinemark股价上涨了57.45%，表明公司势头强劲，投资者对其未来前景以及在不断变化的娱乐格局中适应和蓬勃发展的能力持乐观态度。

The Consumer Discretionary group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Cinemark Holdings (CNK) is a stock that can ...

In a report released today, Eric Handler from Roth MKM maintained a Buy rating on Cinemark Holdings (CNK – Research Report), with a price ...

Charting, Price Performance, News & Related Contracts.

Cinemark Holdings (CNK) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the ...